Pharma Sector

Index
  • 1m
  • 6m
  • ytd
  • 1y
  • 3y
  • 5y
  • max
Constituents (237 Companies)
Company Name
PE
Market Cap (Cr.)
M.Cap (Cr.)
40.57
4,65,711
87.20
1,88,655
33.82
1,13,979
21.95
1,10,613
20.32
1,08,340
54.09
1,03,472
29.86
96,205
25.14
88,119
183
70,680
29.27
67,382
45.45
61,894
38.34
59,505
39.19
44,720
41.10
42,576
39.83
42,059
38.61
35,691
141
30,059
101
25,146
29.24
21,125
31.19
20,658
106
20,000
31.29
19,386
-
18,960
29.22
18,734
52.44
16,892
11.63
16,492
23.20
15,656
50.07
13,063
69.85
12,930
48.79
11,872
29.59
11,870
34.14
11,161
26.70
11,159
61.85
10,966
41.81
10,782
42.21
10,772
16.89
9,392
54.00
9,337
-
8,939
41.15
8,661
25.18
7,802
4.52
7,023
23.79
6,696
55.33
6,384
38.32
5,401
243
5,011
38.14
4,925
41.83
4,818
31.86
4,385
-
4,358
84.15
3,928
15.02
3,797
59.07
3,793
18.95
3,693
34.97
3,566
21.06
3,552
31.07
2,947
42.78
2,881
-
2,699
61.88
2,567
166
2,377
7.10
2,252
-
2,234
18.99
2,206
36.15
2,011
47.66
1,974
41.01
1,974
49.45
1,785
26.69
1,774
22.56
1,482
45.38
1,480
25.48
1,476
33.98
1,464
63.25
1,394
17.74
1,273
16.11
1,231
41.02
1,189
27.07
1,187
21.17
1,180
13.26
1,166
27.03
1,162
47.23
1,087
44.80
1,044
886
1,014
-
990
37.32
960
22.92
848
46.48
825
28.69
798
19.32
793
26.21
767
32.70
672
110
644
42.55
633
20.54
620
52.21
580
30.44
554
26.98
543
27.69
479
22.85
468
13.36
464
94.47
436
-
395
69.58
345
31.40
340
34.07
328
-
327
24.17
317
16.45
313
52.22
290
66.17
287
61.94
280
30.70
278
-
270
13.97
249
-
230
20.63
225
11.32
223
10.52
221
44.34
219
12.50
216
53.54
212
12.69
208
-
201
-
200
39.10
198
7.69
189
-
188
18.88
183
26.91
183
17.81
174
660
171
55.80
167
12.47
163
13.66
161
14.34
155
43.03
152
10.14
152
20.30
151
-
151
16.28
142
9.39
141
22.06
139
95.34
135
38.09
130
18.69
130
20.76
126
24.70
125
68.07
123
29.33
120
-
116
28.68
114
27.08
111
-
108
18.22
105
25.98
105
20.73
100
11.52
97
87.42
92
13.09
91
37.57
88
21.43
84
7.28
83
152
83
-
78
-
74
20.78
71
-
68
-
67
32.14
62
3.47
61
13.65
57
11.51
57
14.15
55
18.68
52
-
51
15.27
48
-
47
-
45
5.02
45
-
44
99.65
44
-
43
18.73
43
-
42
94.27
42
26.03
40
471
39
-
38
24.46
38
8.89
37
5.85
37
17.12
35
-
34
13.23
33
-
31
51.72
31
12.39
31
-
30
23.79
29
-
29
4.69
28
7.81
27
12.35
27
19.38
25
-
24
7.93
24
28.62
24
28.50
22
-
21
-
21
38.62
20
74.75
18
31.38
18
3,482
17
129
16
-
16
-
15
-
13
-
13
163
12
-
12
27.95
12
7.45
12
15.13
11
25.39
11
-
8
-
8
-
7
89.76
7
68.28
6
-
6
-
5
-
4
69.81
4
-
4
-
2
Showing 5 237 of 237 Show More
Market Share

    Select a Metric
    • Gastrointestinal (Nurokind-LC) - Market Share (%)
    • Fermentation Based API Products - Market Share (%)
    • Depression (Placida) - Market Share (%)
    • Birth Control (Unwanted-72) - Market Share (%)
    • Anti Fungal Antibiotics (Terbinaforce) - Market Share (%)
    • Anti-Hypertensives (Amolkind-AT) Market Share (%)
    • Gastro-Intestinal - Market Share (%)
    • Vaccines - Market Share (%)
    • Sex Stimulants - Market Share (%)
    • Pharmaceutical Sector - Market Share (%)
    • Cardiovascular - Market Share (%)
    • Vitamin & Dietary Supplements - Market Share (%)
    • Anti - Diabetes - Market Share (%)
    • Anti-Infectives - Market Share (%)
    Operational Metrics

    Select a Metric
    • Pharma spend as a % of GDP - India (%)
    • Pharma spend as a % of GDP - Korea (%)
    • Pharma spend as a % of GDP - USA (%)
    • Domestic Pharma - Monthly Sales (Crs)
    • Domestic Pharma Price Growth (%)
    • Domestic Pharma Volume Growth (%)
    • Total ANDA's Approved by USFDA

      Select a Metric
      • Fermentation Capacity (KL)
      • No Of Pharmacies (.)
      • Number of ANDA's Approved By USFDA (.)
      • Number of ANDA's Filed in USA (.)
      • Manufacturing Capacity - Metformin (MTPA)
      • No of Pharmacy Outlets - Kolkata (.)
      • Quarterly Sales Volume - Injectables (Nos)
      • Quarterly Sales Volume - Nutraceuticals (Nos)
      • Quarterly Sales Volume - Orals (Nos)
      • Realization / Tonne - Piperazine (Rs/MT)
      • Manufacturing Capacity - Pyridin-3-One (MTPA)
      • Realization / Tonne - Pyridin-3-One (Rs/MT)
      • Domestic Sales Growth - YoY (%)
      • Number of ANDA's Approved (.)
      • Number of ANDA's Filed in Europe
      • Number of ANDA's Approved in Europe
      • Canada DMF fillings (.)
      • US DMF Filings (.)
      • Australia DMF fillings (.)
      • US DMF Approval (.)
      • Europe DMF Filings (.)
      • DMF Filingsby API (.)
      • Total reactor capacity (kL)
      • Global DMFs filed (.)
      • APIs Production Capacity (MTPA)
      • Japan DMF Filings (.)
      • Capacity Utilization - Benzimidazole (%)
      • Realization - Tetralone (Rs/Tonne)
      • Manufacturing Capacity - Omeprazole (MTPA)
      • Capacity Utilization - Esomeprazole (%)
      • Realization - Pantaprazole Sodium (Rs/Tonne)
      • Capacity Utilization - Omeprazole (%)
      • Manufacturing Capacity - Benzimidazole (MTPA)
      • Realization - Chloro Compound (Rs/Tonne)
      • Manufacturing Capacity - Pantaprazole (MTPA)
      • Realization - Op. Sulphide (Rs/Tonne)
      • Realization - Esomeprazole Magnesium (Rs/Tonne)
      • Capacity Utilization - Chloro Compound (%)
      • Capacity Utilization - Pantaprazole (%)
      • Realization - Benzimidazole (Rs/Tonne)
      • Realization - Omeprazole Powder (Rs/Tonne)
      • Manufacturing Capacity - Esomeprazole (MTPA)
      • Manufacturing Capacity - Chloro Compound (MTPA)
      • Realization - Ammonium Sulphate (Rs/Tonne)
      • Manufacturing Capacity - Ibuprofen (MTPA)
      • Capacity Utilization - Pharmaceuticals (%)
      • Number of ANDA's Filed in Canada
      • Number of ANDA's Approved by Canada
      • Number of ANDA's Filed in Australia
      • Number of ANDA's Approved by Australia
      • Number of ANDA's Filed in South Africa
      • Number of ANDA's Approved by South Africa
      • Number of ANDA's Filed in Latam
      • Number of ANDA's Approved by Latam
      • Manufacturing Capacity - Piperazine (MTPA)
      • Manufacturing Capacity - Paracetamol (MTPA)
      • No of Pharmacy Outlets - Hyderabad (.)
      • No of Pharmacy Outlets - Bangalore (.)
      • No of Pharmacy Outlets - Chennai (.)
      Segments

      Select a Metric
      • Therapeutic wise Break-Up - Domestic Pharma (Crs)
      • Dermatology (Crs)
      • Cardiovascular (Crs)
      • Blood Related (Crs)
      • Antineo Plastic (Crs)
      • Anti-Malarial (Crs)
      • Anti - Infectives (Crs)
      • Vaccines (Crs)
      • Stomatological (Crs)
      • Sex Stimulants (Crs)
      • Respiratory (Crs)
      • Pain (Crs)
      • Others (Crs)
      • Ophthalmology (Crs)
      • Neurological (Crs)
      • Gynecology (Crs)
      • Gastro-Intestinal (Crs)
      • Endocrinology (Crs)
      • Urology (Crs)
      • Vitamin & Dietary Supplements (Crs)
      • Anti - Diabetes (Crs)
      • Indian vs MNC - Domestic Share (Crs)
      • Indian (Crs)
      • MNC (Crs)
      Export Import Data

      • 1y
      • 2y
      • 3y
      • 5y
      • 10y
        Select a Metric
        • Pharmaceutical Products (Kgs)
        Ideas Dashboard
        Results
        Timeline
        Watchlist
        Portfolio
        Alerts
        Stock Screener
        Market
        Raw Material